Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
DOCTEUR GENEVIEVE REMACLE - CHIRURGIE GENERALE ET ABDOMINALE from Liège, company number BE0878855533, closed financial year 2025 with a result of € 41,674 after tax. For that financial year DOCTEUR GENEVIEVE REMACLE - CHIRURGIE GENERALE ET ABDOMINALE recorded a gross margin of € 65,254 and equity of € 53,984. Compared with financial year 2024, the result moved from € 25,559 to € 41,674. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.
€ 53,984
▲ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 41,674
▲ 63% vs 2024
Profit after tax over the fiscal year.
€ 70,711
▲ 59% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 34,744 paid out
83 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 142
▼ 94% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 23,898
▲ € 20,833 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -5,316 | € -3,689 | € 29,335 | € 65,254 | ▲ 122% |
| Profit after taxes | € -7,072 | € -4,962 | € 25,559 | € 41,674 | ▲ 63% |
| Equity | € 50,818 | € 45,855 | € 47,054 | € 53,984 | ▲ 15% |
| Total debts | € 796 | € 343 | € 28,482 | € 57,047 | ▲ 100% |
| Cash | € 41,015 | € 18,044 | € 44,607 | € 70,711 | ▲ 59% |
| Retained profit | € 38,418 | € 33,455 | € 34,654 | € 41,584 | ▲ 20% |
| Dividend | € 0 | € 0 | € 24,361 | € 34,744 | ▲ 43% |
| Balance sheet total | € 51,613 | € 46,198 | € 75,535 | € 111,031 | ▲ 47% |
Key figures of DOCTEUR GENEVIEVE REMACLE - CHIRURGIE GENERALE ET ABDOMINALE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DOCTEUR GENEVIEVE REMACLE - CHIRURGIE GENERALE ET ABDOMINALE?
What happened at DOCTEUR GENEVIEVE REMACLE - CHIRURGIE GENERALE ET ABDOMINALE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 41,674 (▲ 63% vs 2024). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 7,072 loss in 2022 to € 41,674 profit in 2025.
Paid € 25,659 in corporate taxes since 2022.
Best year ever: 2025, with € 41,674 profit.
Paid out € 59,105 in dividends to the owners in total.
A new publication or filing at DOCTEUR GENEVIEVE REMACLE - CHIRURGIE GENERALE ET ABDOMINALE? We notify you, reason included.
Follow DOCTEUR GENEVIEVE REMACLE - CHIRURGIE GENERALE ET ABDOMINALEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DOCTEUR GENEVIEVE REMACLE - CHIRURGIE GENERALE ET ABDOMINALE is Genevieve Remacle.
Directors
According to the 2025 annual accounts
Genevieve Remacle
Managing director
Establishments
Establishment units
Physical locations of this company
Avenue de la Rousselière 46
4020 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
OVH Mail
Hosting
OVH, FR
DNS
OVH DNS
Domain
Domain
docteur-remacle.com
Registered
2010-04-16
Registrar
OVH, SAS
Expires
2026-04-16
Website info
Features
Security
Details
- Company number
- 0878.855.533
- VAT number
- BE 0878.855.533
- Registered office
- Avenue de la Rousselière 46, 4020 Liège
- Names & denominations
- DOCTEUR GENEVIEVE REMACLE - CHIRURGIE GENERALE ET ABDOMINALE · MEDIGERE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 January 2006
- Peppol
- Not registered
- Contact
- docteur-remacle.com